Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease

Identifieur interne : 005631 ( Main/Exploration ); précédent : 005630; suivant : 005632

Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease

Auteurs : Bloem [États-Unis] ; Dennis J. Beckley [États-Unis] ; J. Gert Van Dijk [États-Unis] ; Aeilko H. Zwinderman [Pays-Bas] ; Michael P. Remler [États-Unis] ; Raymund A. C. Roos [États-Unis]

Source :

RBID : ISTEX:7D1B413091C4D19EB988526CCD70D44A9EC65628

English descriptors

Abstract

It is still unclear why balance impairment in Parkinson's disease (PD) often responds insufficiently to dopaminergic medication. We have studied this issue in 23 patients with idiopathic PD and 24 healthy controls. Our specific purposes were (a) to investigate the contribution of abnormal automatic postural responses to balance impairment in PD and (b) to assess the influence of dopaminergic medication on abnormal automatic postural responses and balance impairment. Standing subjects received 4° “toe‐up” rotational perturbations of a supporting forceplate. We bilaterally recorded posturally destabilizing medium latency (ML) responses from the stretched gastrocnemius muscles and functionally corrective long latency (LL) responses from the shortened tibialis anterior (TA) muscles. We also assessed changes in the center of foot pressure (CFP) and the center of gravity (COG). All patients were tested “off” and “on” phase. All controls were tested and retested after 1 h. During the off phase, we found enlarged ML amplitudes and diminished LL amplitudes in patients, together with a markedly increased posterior displacement of the COG. The abnormal ML and LL responses were partially responsible for the increased body sway in patients because the initial forward (destabilizing) displacement of the CFP was increased, while the subsequent backward displacement of the CFP (a measure of the corrective braking action of LL responses) was delayed. Abnormal late automatic or possibly more voluntary postural corrections also contributed substantially to the increased body sway. During the on phase, ML amplitudes were reduced in patients but remained increased compared with controls. LL amplitudes no longer differed between both groups due to a modest, possibly dopamine‐related in crease in patients and a simultaneous decrease in controls. The abnormal CFP displacement was only partially improved by dopaminergic medication. The later postural corrections were not improved at all. Consequently, the increased posterior COG displacement was not ameliorated during the on phase. We conclude that (a) a combination of abnormal automatic and perhaps more voluntary postural corrections contributes to increased body sway in PD and (b) dopaminergic medication fails to improve balance impairment in PD because early automatic postural responses are only partially corrected, while later occurring postural corrections are not improved at all. These electrophysiological results support clinical observations and suggest that nondopaminergic lesions play a significant role in the pathophysiology of postural abnormalities in PD.

Url:
DOI: 10.1002/mds.870110506


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease</title>
<author>
<name sortKey="Bloem" sort="Bloem" uniqKey="Bloem" last="Bloem">Bloem</name>
</author>
<author>
<name sortKey="Beckley, Dennis J" sort="Beckley, Dennis J" uniqKey="Beckley D" first="Dennis J." last="Beckley">Dennis J. Beckley</name>
</author>
<author>
<name sortKey="Van Dijk, J Gert" sort="Van Dijk, J Gert" uniqKey="Van Dijk J" first="J. Gert" last="Van Dijk">J. Gert Van Dijk</name>
</author>
<author>
<name sortKey="Zwinderman, Aeilko H" sort="Zwinderman, Aeilko H" uniqKey="Zwinderman A" first="Aeilko H." last="Zwinderman">Aeilko H. Zwinderman</name>
</author>
<author>
<name sortKey="Remler, Michael P" sort="Remler, Michael P" uniqKey="Remler M" first="Michael P." last="Remler">Michael P. Remler</name>
</author>
<author>
<name sortKey="Roos, Raymund A C" sort="Roos, Raymund A C" uniqKey="Roos R" first="Raymund A. C." last="Roos">Raymund A. C. Roos</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7D1B413091C4D19EB988526CCD70D44A9EC65628</idno>
<date when="1996" year="1996">1996</date>
<idno type="doi">10.1002/mds.870110506</idno>
<idno type="url">https://api.istex.fr/document/7D1B413091C4D19EB988526CCD70D44A9EC65628/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000050</idno>
<idno type="wicri:Area/Istex/Curation">000050</idno>
<idno type="wicri:Area/Istex/Checkpoint">003B33</idno>
<idno type="wicri:doubleKey">0885-3185:1996:Bloem:influence:of:dopaminergic</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:8866492</idno>
<idno type="wicri:Area/PubMed/Corpus">004787</idno>
<idno type="wicri:Area/PubMed/Curation">004787</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004808</idno>
<idno type="wicri:Area/Ncbi/Merge">004B95</idno>
<idno type="wicri:Area/Ncbi/Curation">004B95</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004B95</idno>
<idno type="wicri:doubleKey">0885-3185:1996:Bloem B:influence:of:dopaminergic</idno>
<idno type="wicri:Area/Main/Merge">008737</idno>
<idno type="wicri:Area/Main/Curation">005631</idno>
<idno type="wicri:Area/Main/Exploration">005631</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease</title>
<author>
<name sortKey="Bloem" sort="Bloem" uniqKey="Bloem" last="Bloem">Bloem</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Leiden University Hospital, Davis, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, School of Medicine, University of California at Davis, Davis, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Beckley, Dennis J" sort="Beckley, Dennis J" uniqKey="Beckley D" first="Dennis J." last="Beckley">Dennis J. Beckley</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, School of Medicine, University of California at Davis, Davis, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Van Dijk, J Gert" sort="Van Dijk, J Gert" uniqKey="Van Dijk J" first="J. Gert" last="Van Dijk">J. Gert Van Dijk</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Leiden University Hospital, Davis, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zwinderman, Aeilko H" sort="Zwinderman, Aeilko H" uniqKey="Zwinderman A" first="Aeilko H." last="Zwinderman">Aeilko H. Zwinderman</name>
<affiliation wicri:level="3">
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Department of Medical Statistics, State University Leiden, Leiden</wicri:regionArea>
<placeName>
<settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Remler, Michael P" sort="Remler, Michael P" uniqKey="Remler M" first="Michael P." last="Remler">Michael P. Remler</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, School of Medicine, University of California at Davis, Davis, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Roos, Raymund A C" sort="Roos, Raymund A C" uniqKey="Roos R" first="Raymund A. C." last="Roos">Raymund A. C. Roos</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Leiden University Hospital, Davis, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1996-09">1996-09</date>
<biblScope unit="vol">11</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="509">509</biblScope>
<biblScope unit="page" to="521">521</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">7D1B413091C4D19EB988526CCD70D44A9EC65628</idno>
<idno type="DOI">10.1002/mds.870110506</idno>
<idno type="ArticleID">MDS870110506</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Dopamine</term>
<term>Dopamine Agents (adverse effects)</term>
<term>Dopamine Agents (therapeutic use)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Motor Skills (drug effects)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson's disease</term>
<term>Postural Balance (drug effects)</term>
<term>Posture</term>
<term>Pyridinium Compounds (adverse effects)</term>
<term>Pyridinium Compounds (therapeutic use)</term>
<term>Treatment</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Dopamine Agents</term>
<term>Pyridinium Compounds</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Dopamine Agents</term>
<term>Pyridinium Compounds</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Motor Skills</term>
<term>Postural Balance</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Posture</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">It is still unclear why balance impairment in Parkinson's disease (PD) often responds insufficiently to dopaminergic medication. We have studied this issue in 23 patients with idiopathic PD and 24 healthy controls. Our specific purposes were (a) to investigate the contribution of abnormal automatic postural responses to balance impairment in PD and (b) to assess the influence of dopaminergic medication on abnormal automatic postural responses and balance impairment. Standing subjects received 4° “toe‐up” rotational perturbations of a supporting forceplate. We bilaterally recorded posturally destabilizing medium latency (ML) responses from the stretched gastrocnemius muscles and functionally corrective long latency (LL) responses from the shortened tibialis anterior (TA) muscles. We also assessed changes in the center of foot pressure (CFP) and the center of gravity (COG). All patients were tested “off” and “on” phase. All controls were tested and retested after 1 h. During the off phase, we found enlarged ML amplitudes and diminished LL amplitudes in patients, together with a markedly increased posterior displacement of the COG. The abnormal ML and LL responses were partially responsible for the increased body sway in patients because the initial forward (destabilizing) displacement of the CFP was increased, while the subsequent backward displacement of the CFP (a measure of the corrective braking action of LL responses) was delayed. Abnormal late automatic or possibly more voluntary postural corrections also contributed substantially to the increased body sway. During the on phase, ML amplitudes were reduced in patients but remained increased compared with controls. LL amplitudes no longer differed between both groups due to a modest, possibly dopamine‐related in crease in patients and a simultaneous decrease in controls. The abnormal CFP displacement was only partially improved by dopaminergic medication. The later postural corrections were not improved at all. Consequently, the increased posterior COG displacement was not ameliorated during the on phase. We conclude that (a) a combination of abnormal automatic and perhaps more voluntary postural corrections contributes to increased body sway in PD and (b) dopaminergic medication fails to improve balance impairment in PD because early automatic postural responses are only partially corrected, while later occurring postural corrections are not improved at all. These electrophysiological results support clinical observations and suggest that nondopaminergic lesions play a significant role in the pathophysiology of postural abnormalities in PD.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Pays-Bas</li>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
<li>Hollande-Méridionale</li>
</region>
<settlement>
<li>Leyde</li>
</settlement>
</list>
<tree>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Bloem" sort="Bloem" uniqKey="Bloem" last="Bloem">Bloem</name>
</region>
<name sortKey="Beckley, Dennis J" sort="Beckley, Dennis J" uniqKey="Beckley D" first="Dennis J." last="Beckley">Dennis J. Beckley</name>
<name sortKey="Bloem" sort="Bloem" uniqKey="Bloem" last="Bloem">Bloem</name>
<name sortKey="Remler, Michael P" sort="Remler, Michael P" uniqKey="Remler M" first="Michael P." last="Remler">Michael P. Remler</name>
<name sortKey="Roos, Raymund A C" sort="Roos, Raymund A C" uniqKey="Roos R" first="Raymund A. C." last="Roos">Raymund A. C. Roos</name>
<name sortKey="Van Dijk, J Gert" sort="Van Dijk, J Gert" uniqKey="Van Dijk J" first="J. Gert" last="Van Dijk">J. Gert Van Dijk</name>
</country>
<country name="Pays-Bas">
<region name="Hollande-Méridionale">
<name sortKey="Zwinderman, Aeilko H" sort="Zwinderman, Aeilko H" uniqKey="Zwinderman A" first="Aeilko H." last="Zwinderman">Aeilko H. Zwinderman</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005631 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005631 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:7D1B413091C4D19EB988526CCD70D44A9EC65628
   |texte=   Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024